| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |